EDGAR Filing Documents for 0001193125-20-210627

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-20-210627

Filing Date

2020-08-05

Accepted

2020-08-05 16:04:39

Documents

Period of Report

2020-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	d938521d10q.htm iXBRL	10-Q	3598873
2	EX-18	d938521dex18.htm	EX-18	3739
3	EX-31.1	d938521dex311.htm	EX-31.1	10335
4	EX-31.2	d938521dex312.htm	EX-31.2	10320
5	EX-32	d938521dex32.htm	EX-32	4308
	Complete submission text file	0001193125-20-210627.txt		13656661

Data Files

Seq	Description	Document	Type	Size
6	XBRL TAXONOMY EXTENSION SCHEMA	teva-20200630.xsd	EX-101.SCH	79100
7	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	teva-20200630_cal.xml	EX-101.CAL	46326
8	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	teva-20200630_def.xml	EX-101.DEF	522626
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	teva-20200630_lab.xml	EX-101.LAB	534474
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	teva-20200630_pre.xml	EX-101.PRE	562217
11	EXTRACTED XBRL INSTANCE DOCUMENT	d938521d10q_htm.xml	XML	3190712

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131

Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267

TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)